Skip to main content

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

GILD holding history

Gilead Sciences, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GILD overviewAll 13F holders of GILDFull Q2 2026 holdings

Shares (Q2 2026)
2,294,789
Value
$289.9M
% of portfolio
0.2%
Quarters held
20
Since Q1 2021
Holdings of GILD by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,294,789$289.9M0.2%+2,093,870+1,042.1%AddedHolders
Q1 2026200,919$28.0M<0.1%+8,214+4.3%AddedHolders
Q4 2025192,705$23.7M<0.1%−221,057−53.4%ReducedHolders
Q3 2025413,762$45.9M<0.1%−286,466−40.9%ReducedHolders
Q2 2025700,228$77.6M0.1%+246,472+54.3%AddedHolders
Q1 2025453,756$50.8M0.1%−558,706−55.2%ReducedHolders
Q4 20241,012,462$93.5M0.1%+271,261+36.6%AddedHolders
Q3 2024741,201$62.1M0.1%−2,597,051−77.8%ReducedHolders
Q2 20243,338,252$229.0M0.3%+2,203,342+194.1%AddedHolders
Q1 20241,134,910$83.1M0.1%+178,269+18.6%AddedHolders
Q4 2023956,641$77.5M0.1%−1,373,449−58.9%ReducedHolders
Q3 20232,330,090$174.6M0.3%+279,963+13.7%AddedHolders
Q2 20232,050,127$158.0M0.2%+212,149+11.5%AddedHolders
Q1 20231,837,978$152.5M0.2%−178,062−8.8%ReducedHolders
Q4 20222,016,040$173.1M0.3%+1,563,996+346.0%AddedHolders
Q3 2022452,044$27.9M<0.1%−1,319,616−74.5%ReducedHolders
Q2 20221,771,660$109.5M0.2%−3,373,926−65.6%ReducedHolders
Q1 20225,145,586$305.9M0.4%+4,454,256+644.3%AddedHolders
Q4 2021691,330$50.2M0.1%+691,330NewHolders
Q2 20210$00.0%−609,167−100.0%Sold outHolders
Q1 2021609,167$39.4M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.